Hajime Kojima. Commentary to the Discussion on Topics 3, " In Vitro Test Approaches with Bettre Predictivity" at the 5th International Workshop on Genotoxicity Testing. Genes and Environment, 32(2), 40-42, (2010)
Presentations, Speeches
Kojima, H., Arai, S. and Hojyo, M.: Adequate conditions for performance of comet assay using 3-dimensional human epidermal model, 49th Annual SOT meeting, Salt Lake City (2010)
W Stokes, M Wind, D Blakey, J Kreysa, H Kojima, E Anklam: Establishment of the International Cooperation on Alternative Test Methods (ICATM) and Its Role in the Validation and Regulatory Acceptance of Globally Harmonized Safety Assessment Methods, 49th Annual SOT meeting, Salt Lake City (2010)
P Ceger, F Deal, D Allen, G Clark, P Pazos, J de Lange, S Bremer, M Nakamura, H Kojima, A Ono, R Tice, W Stokes, Testing of Coded Substances in the NICEATM/ECVAM/JaCVAM LUMI-CELL® STTA Multiphase International Validation Study, 49th Annual SOT meeting, Salt Lake City (2010.3)
Hajime Kojima. Global impact of 3'Rs on regulatory process: sharing experiences and future trends. XII International Congress of Toxicology, Barcelona, Spain (2010.7)
Hajme Kojima, Thoru Inoue, Yasuo Ohno. JaCVAM's role of new alternatives to animal testing and international　harmonization. XII International Congress of Toxicology, Barcelona, Spain (2010.7)
Kojima, H., Arai, S. and Hojyo M. Importance of each human model and the optimal protocol for regulatory use of skin irritation assay. The 23rd Annual and International Meeting of the Japanese Association for Animal Cell Technology, Hokkaido University, Sapporo, Japan (2010.9)
